From the Research
The UroLift procedure for Benign Prostatic Hyperplasia (BPH) has demonstrated effectiveness for approximately 5 years in most patients, as supported by the most recent and highest quality study available 1. Clinical studies show that the majority of men maintain symptom improvement during this timeframe, with some patients experiencing benefits for longer periods. The procedure works by using small implants to hold the enlarged prostate tissue away from the urethra, creating an open channel for urine flow without cutting, heating, or removing prostate tissue. While some patients may require additional treatments after several years due to continued prostate growth or shifting of the implants, the minimally invasive nature of UroLift makes it an attractive option for many men seeking relief from BPH symptoms. Some key points to consider include:
- Factors such as prostate size, shape, and individual healing responses can affect the duration of effectiveness, and regular follow-up with a urologist is recommended to monitor symptom relief over time 2, 3.
- The procedure is generally most effective for men with prostates under 80 grams without a significant middle lobe enlargement.
- UroLift has a low side-effect profile and is comparable to transurethral resection of the prostate in quality of life changes, and is superior with respect to recovery time and ejaculatory function 1.
- An individualized, shared decision-making approach is essential in selecting the optimal treatment option for each patient 2.